Related Experiment Video
Updated: May 31, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
Building sustainable multiple sclerosis registries in Latin America: A practical framework for real-world evidence
Juan I Rojas1, Liliana Patrucco2, Edgardo Cristiano2
1Unidad de EM y enfermedades desmielinizantes, Servicio de Neurología, Hospital Universitario CEMIC, Buenos Aires, Argentina; Centro de Esclerosis Múltiple de Buenos Aires (CEMBA), Buenos Aires, Argentina.
Abstract:
Real-world evidence (RWE) plays an increasingly important role in multiple sclerosis (MS) and related disorders, complementing randomized clinical trials by capturing effectiveness, safety, treatment persistence, and access patterns in routine care. In Latin America (LATAM), fragmented healthcare systems and structural inequities in access to diagnosis, magnetic resonance imaging (MRI), biomarkers, and high-cost therapies underscore the need for regionally applicable real-world data.
Objectives:
To provide a practical methodological framework for the design, implementation, and sustainability of clinical registries in LATAM, drawing on regional experience in MS and neuromyelitis optica spectrum disorder (NMOSD).
Design/Approach:
Narrative review integrating methodological principles for registry development with lessons learned from the implementation of multicenter MS registries in LATAM. Key domains analyzed include definition of objectives, core dataset selection, representativeness, bias mitigation, governance, data quality assurance, ethical considerations, and sustainability strategies.
Results:
Clinical registries, when based on clearly defined objectives and essential minimum variables, enable standardized longitudinal data collection in routine practice. Regional experience highlights recurrent challenges, including selection bias toward high-complexity centers, missing data, operational burden, and governance conflicts. Pragmatic strategies-such as core datasets, progressive center inclusion, predefined authorship rules, and early dissemination of results-improve feasibility and long-term sustainability. Registries also provide actionable evidence on diagnostic timelines, treatment initiation, persistence, and access disparities, supporting clinical, regulatory, and health technology assessment decisions.
Conclusions:
Well-designed clinical registries represent a strategic platform for generating high-quality RWE in MS and related disorders in LATAM. By combining methodological rigor with operational pragmatism, registries can quantify healthcare gaps, enhance regional collaboration, and contribute to more equitable and evidence-informed decision-making.
Related Concept Videos
Multiple Sclerosis l: Introduction
Principles of Disease Surveillance
Health Literacy
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and case-control studies.
Models of Health Promotion and Illness Prevention II
The agent-host-environment model states that disease results from...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...
